References
- Qi LW, Wang CZ, Yuan CS. Isolation and analysis of ginseng: advances and challenges. Nat Prod Rep. 2011 ; 28(3) : 467-95. https://doi.org/10.1039/c0np00057d
- Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol. 1999 ; 58 : 1685-93. https://doi.org/10.1016/S0006-2952(99)00212-9
- Tian J, Fu F, Geng M, Jiang Y, Yang J, Jiang W, Wang C, Liu K. Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats. Neurosci Lett. 2005 ; 374(2) : 92-97. https://doi.org/10.1016/j.neulet.2004.10.030
- Kim JH, Cho SY, Lee JH, Jeong SM, Yoon IS, Lee BH, Lee JH, Pyo MK, Lee SM, Chung JM, Kim S, Rhim H, Oh JW, Nah SY. Neuroprotective effects of ginsenoside Rg3 against homocysteine- induced excitotoxicity in rat hippocampus. Brain Res. 2007 ; 1136(1) : 190-9. https://doi.org/10.1016/j.brainres.2006.12.047
- Kim S, Kim T, Ahn K, Park WK, Nah SY, Rhim H. Ginsenoside Rg3 antagonizes NMDA receptors through a glycine modulatory site in rat cultured hippocampal neurons. Biochem Biophys Res Commun. 2004 ; 323(2) : 416-24. https://doi.org/10.1016/j.bbrc.2004.08.106
- Kim S, Nah SY, Rhim H. Neuroprotective effects of ginseng saponins against L-type Ca2+ channel-mediated cell death in rat cortical neurons. Biochem Biophys Res Commun. 2008 ; 365(3) : 399-405. https://doi.org/10.1016/j.bbrc.2007.10.048
- Tian J, Zhang S, Li G, Liu Z, Xu B. 20(S)-ginsenoside Rg3, a neuroprotective agent, inhibits mitochondrial permeability transition pores in rat brain. Phytother Res. 2009 ; 23(4) : 486-91. https://doi.org/10.1002/ptr.2653
- Joo SS, Yoo YM, Ahn BW, Nam SY, Kim YB, Hwang KW, Lee do I. Prevention of inflammation-mediated neurotoxicity by Rg3 and its role in microglial activation. Biol Pharm Bull. 2008 ; 31(7) : 1392-6. https://doi.org/10.1248/bpb.31.1392
- Bae EA, Kim EJ, Park JS, Kim HS, Ryu JH, Kim DH. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells. Planta Med. 2006 ; 72(7) : 627-33. https://doi.org/10.1055/s-2006-931563
- O'Banion MK. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol. 1999 ; 13(1) : 45-82. https://doi.org/10.1615/CritRevNeurobiol.v13.i1.30
- Choi SH, Aid S, Bosetti F. The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends Pharmacol Sci. 2009 ; 30(4) : 174-81. https://doi.org/10.1016/j.tips.2009.01.002
- Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol. 2004 ; 63(9) : 901-10. https://doi.org/10.1093/jnen/63.9.901
- Chen QJ, Zhang MZ, Wang LX. Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells. Cell Physiol Biochem. 2010 ; 26(6) : 849-58. https://doi.org/10.1159/000323994
- Kim SM, Lee SY, Yuk DY, Moon DC, Choi SS, Kim Y, Han SB, Oh KW, Hong JT. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch Pharm Res. 2009 ; 32(5) : 755-65. https://doi.org/10.1007/s12272-009-1515-4
- Bae EA, Han MJ, Shin YW, Kim DH. Inhibitory effects of Korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models. Biol Pharm Bull. 2006 ; 29(9) : 1862-7. https://doi.org/10.1248/bpb.29.1862
- Kang KS, Kim HY, Yamabe N, Park JH, Yokozawa T. Preventive effect of 20(S)-ginsenoside Rg3 against lipopolysaccharide-induced hepatic and renal injury in rats. Free Radic Res. 2007 ; 41(10) : 1181-8. https://doi.org/10.1080/10715760701581740
- Henry CJ, Huang Y, Wynne AM, Godbout JP. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav Immun. 2009 ; 23(3) : 309-17. https://doi.org/10.1016/j.bbi.2008.09.002
- Chung DW, Yoo KY, Hwang IK, Kim DW, Chung JY, Lee CH, Choi JH, Choi SY, Youn HY, Lee IS, Won MH. Systemic administration of lipopolysaccharide induces cyclooxygenase-2 immunoreactivity in endothelium and increases microglia in the mouse hippocampus. Cell Mol Neurobiol. 2010 ; 30(4) : 531-41. https://doi.org/10.1007/s10571-009-9477-0
- Jeong HK, Jou I, Joe EH. Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra. Exp Mol Med. 2010 ; 42(12) : 823-32. https://doi.org/10.3858/emm.2010.42.12.085
- Cao C, Matsumura K, Yamagata K, Watanabe Y. Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response. Brain Res. 1995 ; 697(1-2) : 187-96. https://doi.org/10.1016/0006-8993(95)00839-I
- Aid S, Bosetti F. Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications. Biochimie. 2011 ; 93(1) : 46-51. https://doi.org/10.1016/j.biochi.2010.09.009
- Hinz B, Brune K. Cyclooxygenase-2-10 years later. J Pharm Exp Ther. 2002 ; 300 : 367-75. https://doi.org/10.1124/jpet.300.2.367
- Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol. 2004 ; 63(9) : 901-10. https://doi.org/10.1093/jnen/63.9.901
- Wang H, Hitron IM, Iadecola C, Pickel VM. Synaptic and vascular associations of neurons containing cyclooxygenase-2 and nitric oxide synthase in rat somatosensory cortex. Cereb Cortex. 2005 ; 15(8) : 1250-60. https://doi.org/10.1093/cercor/bhi008
- Stefanovic B, Bosetti F, Silva AC. Modulatory role of cyclo- oxygenase-2 in cerebrovascular coupling. Neuroimage. 2006 ; 32(1) : 23-32. https://doi.org/10.1016/j.neuroimage.2006.03.014
- Hewett SJ, Bell SC, Hewett JA. Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous system. Pharmacol Ther. 2006 ; 112(2) : 335-57. https://doi.org/10.1016/j.pharmthera.2005.04.011
- Lee EJ, Son GH, Chung S, Lee S, Kim J, Choi S, Kim K. Impairment of fear memory consolidation in maternally stressed male mouse offspring: evidence for nongenomic glucocorticoid action on the amygdala. J Neurosci. 2011 ; 31(19) : 7131-40. https://doi.org/10.1523/JNEUROSCI.4692-10.2011
- Tan H, Lauzon NM, Bishop SF, Chi N, Bechard M, Laviolette SR. Cannabinoid transmission in the basolateral amygdala modulates fear memory formation via functional inputs to the prelimbic cortex. J Neurosci. 2011 ; 31(14) : 5300-12. https://doi.org/10.1523/JNEUROSCI.4718-10.2011
- Fischborn SV, Soerensen J, Potschka H. Targeting the prostaglandin E2 EP1 receptor and cyclooxygenase-2 in the amygdala kindling model in mice. Epilepsy Res. 2010 ; 91(1) : 57-65. https://doi.org/10.1016/j.eplepsyres.2010.06.012
- Vidensky S, Zhang Y, hand T, Goellner J, Shaffer A, Isakson P, Andreasson K. Neuronal overexpression of COX-2 results in dominant production of PGE2 and altered fever response. Neuromolecular Med. 2003 ; 3(1) : 15-28. https://doi.org/10.1385/NMM:3:1:15
- Quan N, Whiteside M, Herkenham M. Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide. Brain Res. 1998 ; 802(1-2) : 189-97. https://doi.org/10.1016/S0006-8993(98)00402-8